Status:

COMPLETED

Retrospective Evaluation of the Percentage of Subjects Who Have Reached Their LDL-C Objectives After Treatment With INEGY (Study P05103)(COMPLETED)

Lead Sponsor:

Organon and Co

Conditions:

Primary Hypercholesterolemia

Eligibility:

All Genders

18+ years

Brief Summary

The main objective of this study is to determine the percentage of patients who met the low-density lipoprotein cholesterol (LDL-C) objective with INEGY, that were not under statin monotherapy treatme...

Detailed Description

The type of patient sampling used was consecutive patient sampling

Eligibility Criteria

Inclusion

  • man or woman aged over 18;
  • patient suffering from primary hypercholesterolemia;
  • patient justifying treatment with INEGY® (2nd intention);
  • patient currently treated with INEGY® for at least 4 weeks;
  • patient with a lipid profile before treatment with INEGY®, documenting a level of LDL-C exceeding the therapeutic objective under treatment with a statin as monotherapy;
  • patient with an evaluation of lipid disorder (EAL) treated with INEGY®, performed within 1 to 3 months of starting treatment.

Exclusion

  • patient not previously treated with a statin;
  • patient previously treated with a combination of hypolipemics;
  • patient treated with INEGY® as first intention;
  • patient treated with INEGY® for less than 4 weeks;
  • patient already included in this study.

Key Trial Info

Start Date :

October 1 2007

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

August 1 2008

Estimated Enrollment :

1663 Patients enrolled

Trial Details

Trial ID

NCT00724477

Start Date

October 1 2007

End Date

August 1 2008

Last Update

February 9 2022

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.